MedTrace Logo

A Pilot Clinical Trial Investigating the Effect of Cutaneous Cooling on Sebum Production

NCT01686841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2025-09-18

Study results available
· View outcomes & findings →

Summary

To evaluate the safety and feasibility of reducing human sebum production using the ZELTIQ System.

Conditions

Interventions

DEVICE

The Zeltiq System

Non-invasive cooling is applied to the treatment area with a defined cooling rate and duration.

Sponsors & Collaborators

  • Zeltiq Aesthetics

    lead INDUSTRY

Principal Investigators

  • Rox Anderson, MD · MGH

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-16
Primary Completion
2013-04-29
Completion
2013-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01686841 on ClinicalTrials.gov